Product Description: D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro[1].
Applications: Neuroscience-Neuromodulation
Formula: C6H13NO2
References: [1]Xiaoyu Cao, et al. Combination of PARP Inhibitor and Temozolomide to Suppress Chordoma Progression. J Mol Med (Berl). 2019 Aug;97(8):1183-1193
CAS Number: 328-38-1
Molecular Weight: 131.17
Compound Purity: 98.0
Research Area: Neurological Disease
Solubility: DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C)/H2O : 10 mg/mL (ultrasonic;warming;heat to 60°C)